Brief: Pacira Biosciences FY Adjusted Net Income USD 142 Million
29/02/2024 13:00
Feb 29 (Reuters) - Pacira Biosciences FY revenue USD 675 million vs. IBES estimate USD 676.5 million. * FY adjusted EBITDA USD 214 million * FY net income USD 42 million
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees